JMAC Enterprises LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing ownership of 121 equity securities as of the close of business on September 30, 2026. The filing lists Robert Macaulay, Chief Compliance Officer, as the authorized representative for the firm, which is headquartered at 201 South State St Suite 2A in Newtown, PA.
The portfolio is diversified across a wide range of sectors, including consumer staples, healthcare, technology, and energy. Major individual stock holdings include Unilever PLC, Abbott Laboratories, McCormick & Co., and Colgate-Palmolive Co. The portfolio also includes significant positions in technology companies such as Tesla, Meta Platforms, and Amazon, alongside financial institutions like Bank of America and JPMorgan Chase & Co.
In addition to individual equities, the filing reveals substantial exposure to exchange-traded funds (ETFs). The top ETF holdings include the iShares Core S&P 500 ETF, the iShares Core S&P Mid-Cap ETF, and the iShares Core S&P Total Stock Market ETF. Other notable ETF positions include the Invesco S&P 500 Equal Weight ETF, the iShares 0-5 Year High Yield Corporate Bond ETF, and the SPDR S&P 500 ETF Trust.
The filing also lists exposure to other asset classes, including commodities. The portfolio holds shares in the SPDR Gold Shares and the iShares Gold Trust. Furthermore, the portfolio includes positions in various sector-specific ETFs, such as the Select Sector SPDR Trust – Utilities, Financials, and Technology ETFs, as well as the iShares Expanded Tech ETF and the Vanguard World Fund Health Care ETF.
